-
E068 Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2
Xenofon Baraliakos, Sofía Ramiro, Marina Magrey, Martín Rudwaleit, Nigil Haroon, Carmen Fleurinck, +5 more
0citations -
P180 Minimal spinal radiographic progression in patients with radiographic axial spondyloarthritis over 2 years of bimekizumab treatment: results from a phase 3 open-label extension study2025 Lara D. Veeken conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Xenofon Baraliakos, Sofía Ramiro, Walter P. Maksymowych, Mikkel Østergaard, Ute Massow, Thomas Vaux, +3 more
0citations -
P115 Long-term efficacy of filgotinib monotherapy and combination therapy: interim results from a post hoc analysis of the FINCH 4 study2025 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Maya H Buch, Patrick Verschueren, Roberto Felice Caporali, Tom W. J. Huizinga, Edmund V Ekoka Omoruyi, Dick de Vries, +2 more
0citations -
OA10 Systematic review and independent validation of genetic factors of radiographic outcome in rheumatoid arthritis identifies a genome-wide association with CARD92025 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Seema Sharma, Ryan Malcolm Hum, Nisha Nair, Lysette Marshall, John Bowes, Alex J. MacGregor, +6 more
0citations -
OA12 An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years2025 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Kevin L. Winthrop, Daniel Aletaha, Roberto Felice Caporali, Yoshiya Tanaka, Tsutomu Takeuchi, Maya H Buch, +6 more
0citations -
Responsiveness of spondyloarthritis-specific health utilities based on the ASAS Health Index (U-ASAS-HI): an ancillary analysis from the ASAS-HI validation study
Omar-Javier Calixto, Xenofon Baraliakos, Annelies E. R. C. H. Boonen, Wilson Bautista‐Molano, Ivette Essers, Désirée M F M van der Heijde, +2 more
0citations -
Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc
A M Alzahrani, Stefan F. H. Neys, Wieke M. van Oostveen, Saad Ahmed, E W N Levarht, Rudi W. Hendriks, +5 more
0citations